GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of new glucomimetic drugs to address unmet medical needs resulting from disease in the United States. The company is headquartered in Rockville, Maryland.
Click "Analyze" to generate stock analysis
GLYC Price Trend and Signals
2025-06-13Somewhat Bearishprice_signal
Half-yearly low detected.
2025-06-12Somewhat Bearishprice_signal
Half-yearly low detected.
2025-06-11Somewhat Bearishprice_signal
Half-yearly low detected.
2025-06-10Somewhat Bearishprice_signal
Half-yearly low detected.
2025-06-09Somewhat Bearishprice_signal
Half-yearly low detected.
2025-06-06Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-06-06Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-06-06Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-06-06Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-06-06Somewhat Bearishprice_signal
Monthly low detected.
2025-06-05Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-06-05Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-06-05Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-06-05Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.